• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate

Month: October 2021


Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer

Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer

by Covid Strategies | Oct 28, 2021 | Featured, Science & News

By Mariana Chavez-MacGregor, MD, MSC Key Points Question  What are the rates of death, mechanical ventilation, intensive care unit stay, and hospitalization among patients with COVID-19 with or without cancer? Findings  In this cohort study of...

read more
Antidepressant May Cut COVID-Related Hospitalization, Mortality: TOGETHER Published

Antidepressant May Cut COVID-Related Hospitalization, Mortality: TOGETHER Published

by Covid Strategies | Oct 28, 2021 | Featured, Mainstream Solutions, Mainstream Treatment, Repurposed Drugs

By Esther Landhuis The antidepressant fluvoxamine (Luvox) may prevent hospitalization and death in outpatients with COVID-19, new research suggests. Results from the placebo-controlled, multisite, phase 3 TOGETHER trial showed that in COVID-19 outpatients at...

read more
Aspirin lowers risk of COVID: New findings support preliminary Israeli trial

Aspirin lowers risk of COVID: New findings support preliminary Israeli trial

by Covid Strategies | Oct 27, 2021 | Featured, Integrative Prevention, Mainstream Solutions, Mainstream Treatment

The treatment reduced the risk of reaching mechanical ventilation by 44%. ICU admissions were lower by 43%, and an overall in-hospital mortality saw a 47% decrease. Originally published in The Jerusalem Post on October 6, 2021 Over-the-counter aspirin could protect...

read more
CDC Slips in Guideline that Immunocompromised Can Get Fourth Dose

CDC Slips in Guideline that Immunocompromised Can Get Fourth Dose

by Covid Strategies | Oct 27, 2021 | Mainstream Prevention, Mainstream Solutions, Vaccines

Apparently, the shots may keep coming—especially for the immunocompromised—as the Centers for Disease Control and Prevention (CDC) updated their guidelines. The CDC considers this fourth shot an actual “booster.” As it turns out, the CDC suggests that those with...

read more
Needle Points

Needle Points

by Covid Strategies | Oct 27, 2021 | Featured, Mainstream Prevention, Mainstream Solutions, Vaccines

Why so many are hesitant to get the COVID vaccines, and what we can do about it. BY NORMAN DOIDGE ‘Needle Points,’ Tablet’s exploration into the sources and nature of vaccine hesitancy, is presented in four parts. Chapter I begins below. Continue to Chapter II, III,...

read more
Cheap antidepressant shows promise treating early COVID-19

Cheap antidepressant shows promise treating early COVID-19

by Covid Strategies | Oct 27, 2021 | Featured, Mainstream Solutions, Repurposed Drugs

By CARLA K. JOHNSON A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus. Researchers tested the pill used for depression and...

read more
COVID SCIENCE-Breakthrough infections can lead to long COVID; genes may explain critical illness in young, healthy adults

COVID SCIENCE-Breakthrough infections can lead to long COVID; genes may explain critical illness in young, healthy adults

by Covid Strategies | Oct 27, 2021 | Featured, Long Haul

By Nancy Lapid Oct 27 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Breakthrough infections can lead to long...

read more
Republicans Spin NIH Letter About Coronavirus Gain-of-Function Research

Republicans Spin NIH Letter About Coronavirus Gain-of-Function Research

by Covid Strategies | Oct 26, 2021 | Science & News

By Jessica McDonald Republicans say a letter from a National Institutes of Health official is an admission that the agency funded so-called gain-of-function research on bat coronaviruses in China, with some falsely linking the work to the pandemic coronavirus. But the...

read more
Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines

by Covid Strategies | Oct 26, 2021 | Mainstream Prevention, Mainstream Solutions, Vaccines

By Jiping Liu, et al. Abstract Large-scale COVID-19 vaccinations are currently underway in many countries in response to the COVID-19 pandemic. Here, we report, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and...

read more
Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination

Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination

by Covid Strategies | Oct 26, 2021 | Mainstream Prevention, Mainstream Solutions, Vaccines

By Lily Li, MD, et al. Key Points Question  What is the association between self-reported history of high-risk allergy and allergic reactions after messenger RNA (mRNA) COVID-19 vaccination? Findings  In this cohort study of 52 998 health...

read more
Doctors are often unaware of the only treatment for early Covid-19

Doctors are often unaware of the only treatment for early Covid-19

by Covid Strategies | Oct 25, 2021 | Featured, Mainstream Treatment

By Elizabeth Cohen On September 17, Mayra Arana made the phone call she says saved her life.Arana had been vaccinated against Covid-19, but she developed a breakthrough infection. She feared the virus might kill her, since her immune system is weak after years of...

read more
Their Jobs Made Them Get Vaccinated. They Refused.

Their Jobs Made Them Get Vaccinated. They Refused.

by Covid Strategies | Oct 24, 2021 | Featured, Mainstream Prevention, Mainstream Solutions, Vaccines

The willingness of some workers to give up their livelihoods helps explain the country’s struggle to contain the pandemic. By Sarah Maslin Nir Under the threat of losing their jobs, hundreds of thousands of New Yorkers finally got a Covid-19 vaccine. Teachers, nurses...

read more
Can Intranasal Vaccines Stop Breakthrough COVID?

Can Intranasal Vaccines Stop Breakthrough COVID?

by Covid Strategies | Oct 23, 2021 | Featured, Mainstream Prevention, Mainstream Solutions, Vaccines

— Systematic vaccination is necessary but may not be sufficient for those at high risk by Daniel Teres, MD, Diana M. Stone, PhD, MPH, DVM, and Martin A. Strosberg, PhD, MPH he recent surge of COVID-19 in the southern U.S. in summer and early fall was...

read more
After Strong Denials, NIH Admits Funded Gain-of-Function Research at Wuhan Lab

After Strong Denials, NIH Admits Funded Gain-of-Function Research at Wuhan Lab

by Covid Strategies | Oct 23, 2021 | Science & News

According to an October 21 report from Yahoo News, the NIH has now admitted to paying for Gain-of-Function work at the Wuhan Institute of Virology. At the same time, NIH is pointing the finger at its contractor EcoHealth Alliance for violating reporting...

read more
What to Know About Mixing and Matching Your Covid-19 Booster

What to Know About Mixing and Matching Your Covid-19 Booster

by Covid Strategies | Oct 22, 2021 | Mainstream Prevention, Mainstream Solutions, Vaccines

For those who need boosters, the mix-and-match approach with the various vaccines seems to be safe and effective. By Ed Cara On Thursday night, Rochelle Walensky, head of the Centers for Disease Control and Prevention, gave the green light to boosters for...

read more
Page 2 of 7«12345…»Last »

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home